Transactions

Innoviva, Inc.’s strategic repurchase of GlaxoSmithKline plc’s 32% equity stake

Date Announced:
05/20/2021

client:
Innoviva, Inc.

Status:
Closed – 05/25/2021

Value:
$392 million


Download CSV